PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibition and Stroke Prevention
Author(s) -
Mark J. Alberts,
Paul M. Thompson
Publication year - 2020
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.120.028567
Subject(s) - subtilisin , kexin , pcsk9 , medicine , proprotein convertase , stroke (engine) , evolocumab , cholesterol , lipoprotein , ldl receptor , mechanical engineering , biochemistry , chemistry , engineering , enzyme , apolipoprotein a1
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom